Table of Contents

company-logo

Arovella Therapeutics Limited, a biotechnology company, focuses on the development of therapies for the treatment of cancer and conditions that affect the central nervous system in Australia and internationally. Its product pipeline includes ZolpiMist, an oral spray of zolpidem tartrate to treat short-term insomnia, which is marketed under the brand name of Ambien or Stilnox; invariant natural killer T (iNKT), a cell therapy platform to treat blood cancer; OroMist, an oro-mucosal technology that delivers a range of drug classes through the cheeks, gums, tongue, or floor of the mouth; and Anagrelide to treat cancer. The company also develops oral sprays to treat migraine headaches, motion sickness, and drug-resistant epilepsy. It has a collaborative research agreement with Imperial College London. The company was formerly known as Suda Pharmaceuticals Ltd and changed its name to Arovella Therapeutics Limited in October 2021. Arovella Therapeutics Limited was incorporated in 1999 and is headquartered in Osborne Park, Australia.

Arovella Therapeutics Dividend Announcement

• Arovella Therapeutics does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Arovella Therapeutics dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Arovella Therapeutics Dividend History

Arovella Therapeutics Dividend Yield

Arovella Therapeutics current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Arovella Therapeutics stock? Use our calculator to estimate your expected dividend yield:

Arovella Therapeutics Financial Ratios

P/E ratio-16.96
PEG ratio-0.89
P/B ratio16.19
ROE-149.27%
Payout ratio0.00%
Current ratio6.45
Quick ratio6.45
Cash Ratio6.23

Arovella Therapeutics Dividend FAQ

Does Arovella Therapeutics stock pay dividends?
Arovella Therapeutics does not currently pay dividends to its shareholders.
Has Arovella Therapeutics ever paid a dividend?
No, Arovella Therapeutics has no a history of paying dividends to its shareholders. Arovella Therapeutics is not known for its dividend payments.
Why doesn't Arovella Therapeutics pay dividends?
There are several potential reasons why Arovella Therapeutics would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Arovella Therapeutics ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Arovella Therapeutics has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Arovella Therapeutics a dividend aristocrat?
Arovella Therapeutics is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Arovella Therapeutics a dividend king?
Arovella Therapeutics is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Arovella Therapeutics a dividend stock?
No, Arovella Therapeutics is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Arovella Therapeutics stocks?
To buy Arovella Therapeutics you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Arovella Therapeutics stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.